Xlife Sciences AG Cash Flow Reinvestment Rate

Latest as of December 2023: 0.24x

Xlife Sciences AG cash flow reinvestment rate. Xlife Sciences AG (XLS) has a Cash Flow Reinvestment Rate of 0.24x as of December 2023, reinvesting CHF41.08K (capex CHF41.08K ) from operating cash flow of CHF171.78K. Explore Xlife Sciences AG debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.24x

(Capex + Investments) / Operating CF

Total Reinvested

CHF41.08K

Capex + Investments

Operating Cash Flow

CHF171.78K

CHF

Capital Expenditures

CHF41.08K

CHF

Cash Flow Reinvestment Rate of Xlife Sciences AG (2023–2023)

Cash flow reinvestment rate of Xlife Sciences AG from 2023 to 2023. Historical reinvestment intensity for Xlife Sciences AG across 1 annual periods. Explore XLS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Xlife Sciences AG Cash Flow Reinvestment Rate by Year (2023–2023)

Xlife Sciences AG cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for Xlife Sciences AG. For the full cash flow conversion analysis, see Xlife Sciences AG (XLS) cash conversion ratio.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2023	6.14x	CHF1.06 Million	CHF171.78K	CHF41.08K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow